Stocktoria
SkinHealth Systems Inc. SKIN
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-02-10
SkinHealth Systems Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 65.3% | 54.5% | 39.0% | 68.0% | 68.6% |
| Operating margin | -6.9% | -20.3% | -32.9% | -7.1% | -15.4% |
| Net margin | -3.2% | -8.7% | -25.2% | 12.1% | -145.6% |
| FCF margin | 12.4% | 4.6% | 4.5% | -32.1% | -15.2% |
| Return on assets | -1.9% | -4.2% | -10.8% | 4.4% | -31.1% |
| Return on equity | -15.6% | -56.2% | -168.6% | 26.5% | -127.1% |
| Debt / equity | — | 10.66× | — | — | — |
| Current ratio | 1.66 | 7.00 | 6.07 | 10.92 | 13.09 |
| Revenue growth | -10.0% | -16.0% | 8.8% | 40.7% | 118.4% |
Source: SEC EDGAR filings · CIK 0001818093 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.